The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $64.74

Today's change-0.08 -0.12%
Updated February 8 3:43 PM EST. Delayed by at least 15 minutes.
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $64.74

Today's change-0.08 -0.12%
Updated February 8 3:43 PM EST. Delayed by at least 15 minutes.

MEDNAX Inc down (U.S.)$0.08

MEDNAX Inc is lower today, dropping (U.S.)$0.08 or 0.12% to (U.S.)$64.74. Over the last five days, shares have lost 6.90% and are down 9.66% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $64.01
  • Previous close(U.S.) $64.82
  • High(U.S.) $64.76
  • Low(U.S.) $62.79
  • Bid / Ask(U.S.) $64.72 / (U.S.) $64.76
  • YTD % change-9.66%
  • Volume1,193,924
  • Average volume (10-day)1,069,891
  • Average volume (1-month)881,662
  • Average volume (3-month)972,770
  • 52-week range(U.S.) $61.40 to (U.S.) $86.09
  • Beta0.73
  • Trailing P/E18.08×
  • P/E 1 year forward15.33×
  • Forward PEG1.02×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.58
Updated February 8 3:43 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.08%

Based on its net profit margin of 12.08%, MEDNAX Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.80%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue742722677639
Total other revenue--------
Total revenue742722677639
Gross profit255248229196
Total cost of revenue487474448443
Total operating expense591571536525
Selling / general / administrative85807268
Research & development--------
Depreciation / amortization18171614
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income151151141115
Interest income (expense), net non-operating-8-6-5-3
Gain (loss) on sale of assets--------
Other--------
Income before tax144146137113
Income after tax92918469
Income tax, total52565344
Net income93918469
Total adjustments to net income--------
Net income before extra. items93918469
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items93918469
Inc. avail. to common incl. extra. items93918469
Diluted net income93918469
Dilution adjustment--------
Diluted weighted average shares94949395
Diluted EPS excluding extraordinary itemsvalue per share0.990.970.900.72
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.990.970.900.72